期刊文献+

胶体纳米银对产超广谱β-内酰胺酶肺炎克雷伯菌的抑制作用 被引量:2

Inhibitory effect of colloidal silver nanoparticles on extended spectrum beta-lactamase-producing Klebsiella pneumonia
原文传递
导出
摘要 目的探讨胶体纳米银对产超广谱β-内酰胺酶(ESBLs)肺炎克雷伯菌的抑制作用。方法以产ESBLs肺炎克雷伯菌为研究对象,采用涂布法检测杀菌作用,肉汤微量稀释法测量最低抑菌浓度(MIC),电镜法观察胶体纳米银对产ESBLs肺炎克雷伯菌的作用机理。结果≥0.5μg/mL的胶体纳米银对产ESBLs的肺炎克雷伯菌具有100%杀菌作用;≥0.05μg/mL的胶体纳米银对产ESBLs的肺炎克雷伯菌也具有明显的杀菌作用;5μg/mL胶体纳米银对产ESBLs肺炎克雷伯菌5、15、30和60 min均有明显的杀菌作用;胶体纳米银对产ESBLs肺炎克雷伯菌的MIC为3.125μg/mL;不同因素对胶体纳米银的杀菌作用,蛋白因素影响显著(P<0.05);胶体纳米银对产ESBLs肺炎克雷伯菌的形态学有明显影响。结论胶体纳米银对产ESBLs肺炎克雷伯菌具有明显的抑制作用,这些结果将为胶体纳米银的临床应用提供了实验依据。 Objective To explore the inhibitory effect of colloidal silver nanoparticles on extended spectrum beta-lactamases(ESBLs)-producing Klebsiella pneumonia.Methods The spread plate method was used to detect the bactericidal effect,broth microdilution method to measure the minimum inhibitory concentration(MIC),and electron microscopy to observe the effect of colloidal silver nanoparticles on ESBLs-producing Klebsiella pneumonia.Results≥0.05μg/mL of silver nanoparticles had 100%bactericidal effects on ESBLs-producing Klebsiella pneumonia;0.05μg/mL of silver nanoparticles also had obvious bactericidal effects;5μg/mL of silver nanoparticles had distinct bactericidal effect on ESBLs-producing Klebsiella pneumonia in 5 min,15 min,30 min and 60 min,respectively.The MIC was 3.125μg/mL.Protein had obvious influence on the bactericidal effect of colloidal silver nanoparticles.Evident effect of nano silver on the morphology of ESBLs-producing Klebsiella pneumonia was seen under the electron microscope.Conclusion Colloidal silver nanoparticles have obvious inhibitory effect on ESBLs-producing Klebsiella pneumonia.The result will provide an experimental basis for the clinical application of colloidal silver nanoparticles.
出处 《中国微生态学杂志》 CAS CSCD 2017年第3期288-291,共4页 Chinese Journal of Microecology
关键词 胶体纳米银 产超广谱β-内酰胺酶肺炎克雷伯菌 抑制作用 Colloidal silver nanoparticles ESBLs-producing Klebsiella pneumonia Inhibition
  • 相关文献

参考文献1

二级参考文献5

  • 1Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Suscepthility Testing [S]. Fifteenth infor mational supplement. Approved standard M100-S15. Wayne, PA. 2005.
  • 2Tasli H, Bahar IH. Molecular characterization of TEM-and SHV derived extended-spectrim beta lactamases in hospitalbased Enterobacteriaceae in Turkey [J]. Jpn J Infect Dis, 2005, 58(3) :162-167.
  • 3Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes[J]. Antimierob Agents Chemother,2004, 48(1) : 1-14.
  • 4朱德妹,张婴元,汪复.2007年上海地区细菌耐药性监测[J].中国感染与化疗杂志,2008,8(6):401-410. 被引量:49
  • 5孙景勇,倪语星.大肠埃希菌和肺炎克雷伯菌超广谱β内酰胺酶的基因分型[J].中国抗感染化疗杂志,2002,2(4):211-214. 被引量:50

共引文献11

同被引文献16

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部